Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Medical Device Classification and FDA Approva:What Startups Need to Know

Bio Spectrum

|

BioSpectrum India May 2025

For many innovators, the United States represents a key market, being the world’s largest for medical devices.

- Aishwarya Varpe, Associate- Regulatory Services, Venture Center

Medical Device Classification and FDA Approva:What Startups Need to Know

However, entering the US market requires navigating the US Food and Drug Administration’s (FDA) stringent regulatory landscape, where accurate device classification is crucial. To assist innovators, the Regulatory Information and Facilitation Center (RIFC) at Venture Center, Pune has released a whitepaper early this year that offers practical insights, featuring examples of devices developed by Venture Center-supported startups to illustrate how medical devices are categorised based on risk.

Under the FDA, the Center for Devices and Radiological Health (CDRH) oversees the regulation of medical devices. It ensures that patients and healthcare providers have timely and sustained access to safe, effective, and high-quality medical devices, including radiation-emitting products.

To assist innovators, the Regulatory Information and Facilitation Center (RIFC) at Venture Center has released a whitepaper titled "Classification of Medical Devices in the US", providing a simplified step-by-step guide in the form of a flowchart on determining device classification (Class I, II, III), regulatory pathways (510(k), De Novo, PMA), and key compliance requirements with examples. The whitepaper also offers practical insights, featuring examples of devices developed by Venture Center-supported startups to illustrate how medical devices are categorised based on risk.

Bio Spectrum からのその他のストーリー

Bio Spectrum

Bio Spectrum

Building Breakthrough Medical Devices

Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Bridging classical epidemiology with modern science

A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

"AI, Automation & Analytics: A new era of modern microbiology testing!"

Pharmaceutical manufacturing is undergoing a paradigm shift.

time to read

4 mins

January 2026

Bio Spectrum

Bio Spectrum

The CRISPR Moment

CRISPR (clustered regularly interspaced short palindromic repeats) technology is ushering in a new era of gene and cell therapy, offering more precision and potential for treating genetic disorders, cancer, and infectious diseases.

time to read

2 mins

January 2026

Bio Spectrum

Leveraging Microfluidic Technology for mRNA-LNP Manufacturing

Over the past five years, messenger RNA (mRNA) therapeutics have evolved from experimental concepts into lifesaving medicines.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Demonstrating India's Vaccine Capabilities

Havisure is India's first and only indigenously developed Hepatitis A vaccine, to address one of the country's most persistent public health challengeswidespread Hepatitis A infections caused by inadequate sanitation and contaminated food and water.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

Inspiring Future Generations

A PhD in molecular biology from the University of Cambridge, UK, Prof. Gaiti Hasan is a Distinguished Fellow at the National Centre for Biological Sciences (NCBS), Bengaluru.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

A Landmark for India's Antibiotic Innovation

After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country's first indigenous antibiotic.

time to read

2 mins

January 2026

Bio Spectrum

Bio Spectrum

"Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”

TechInvention Lifecare Limited, a vaccine focused biotechnology company headquartered in Mumbai, is recognised for its innovative contributions to global healthcare.

time to read

4 mins

January 2026

Bio Spectrum

Bio Spectrum

Telangana: Building India's Most Credible Life Sciences Ecosystem

Telangana's recognition as BioSpectrum India's Best Performing State in Life Sciences 2025 is a timely validation of the direction the state has taken in recent years-one anchored in execution, responsiveness, and a clear understanding of where global life sciences value chains are headed.

time to read

4 mins

January 2026

Listen

Translate

Share

-
+

Change font size